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Vitiligo is an autoimmune disease that causes melanocyte of dysfunction. 
Cytokines played an important role in the pathogenesis of vitiligo. Interferon-
gamma and TNF-  were cytokines that induce apoptosis of melanocyte cell. 
The increase of cytokine levels affects the clinical course of vitiligo. The stable 
and progressive phase of vitiligo clinically is not easy to predict. Assessment of 
vitiligo stability could be used to determine treatment options, duration of 
therapy and prognosis. This study was a cross-sectional observational study 
which intended to prove high levels of TNF-α and IFN- serum is a risk factor 
for vitiligo progression. The demographic, clinical, and laboratory data in active 
vitiligo subjects (n=30) were compared with stable vitiligo subjects   (n=40).   
The relationship was analyzed with multivariate. Median of the subject age 
with active vitiligo was 44 years (860) and on the subject with stable vitiligo 
was 45 years (1566). The most subjects were male (58.5%) and the most 
common type of vitiligo was non-segmental vitiligo (87.1%). Multivariate 
analysis showed a high level of TNF- serum increased the risk of vitiligo 
progressivity (Adjusted PR 390.89; CI 95 % 27.98-5460.12 ; p<0,001) and high 
level of IFN- serum increased the risk of vitiligo progressivity (Adjusted PR 
341.06; CI 95% 33.40-3482.26 ; p<0,001). The high level of TNF- and IFN- 
serum as a risk factor for progression of vitiligo could be used to assess the 
activity of vitiligo disease. The further research about the association between 
TNF-  and IFN- to predict the therapeutic response in vitiligo.  
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1.  Introduction 
Vitiligo is a skin depigmentation disorder of the skin, hair, and mucosa. Which is characterized by 
functional melanocyte defect in the epidermis. Pathogenesis of vitiligo is a complex pathological 
mechanism involving cellular and humoral immunity, induced by the cytokine expression imbalance in 
the skin, serum, and blood in vitiligo patients [1], [2]. Tumor necrosis alpha is a multifunctional 
proinflammatory cytokine that plays an important role in apoptosis through the activation of 
receptor-mediated apoptosis in various cells. Keratinocytes interact closely with melanocytes, secrete 
TNF- which acts as an inhibitor in melanocyte proliferation and melanogenesis. It causes the initiation 
of melanocyte apoptosis and inhibits melanocyte stem cell differentiation [3]. Other pro-
inflammatory cytokines that are involved in the pathogenesis of vitiligo are IFN-produced by 
Th1 lymphocytes, NK cells, and CD8+ cytotoxic T cells. Interferon-gamma affects melanin production, 
melanosomes maturation induces the formation of anti-melanocyte antibodies and activation of 
cytotoxic T cells which further leads to melanocyte apoptosis [4], [5]. 
The clinical course of vitiligo is difficult to predict as it involves stable phase and active phase or 
spontaneously regression. The previous studies have shown that in stable vitiligo, there are low levels of 
pro-inflammatory cytokines and low numbers of cytotoxic T cells [6]. Progressive/active vitiligo can 
be assessed by the pres enc e of ne w  lesions, the  proliferation of old lesions, grafting tests  and  
Koebner phenomena, VASI and VIDA scores. These parameters are subjective and semi- subjective [7], 
[8]. The higher level of TNF- and IFN- is more objective in predicting the progression of vitiligo. In 
vitiligo, the treatment choices, treatment duration, and prognosis could be determined by assessing the 
course of vitiligo disease [9]. 
 
2.  Research Method 
The study used a cross-sectional observational design. The research subject is vitiligo patients who 
visited the Dermatology and Venereology polyclinics at Sanglah Hospital, Denpasar Bali. The number of 
research samples was 70 vitiligo patient. They were chosen by consecutive sampling based on inclusion 
and exclusion criteria. The VASI score was used as vitiligo severity assessment. Vitiligo activity degree 
was assessed using VIDA score. Demographic and clinical data were obtained using a questionnaire. The 
serum level of TNF- and IFN- were assessed using ELISA technique by drawing venous blood. The 
samples were divided into two groups, active vitiligo, and stable vitiligo.  Active vitiligo defined by new 
lesions or expanding of old lesions within the last one year with the VIDA score 1. Stable vitiligo defined 
as a nonexpanding old lesion and/or no new lesion within the last one year with VIDA score of 0. 
The data were analyzed using IBM SPSS Statistics ver. 20. Descriptive analysis was used to describe 
characteristics of subjects with vitiligo, such as age, gender, and clinical manifestation. Data normality 
was assessed using Shapiro Wilk test. Bivariate analysis using chi-square were applied to observe 
associations between qualitative variables. Multivariate analysis using logistic regression was performed 
to observe adjusted prevalence ratios (PR) with 95% confidence intervals. A p-value of <0,05 was 
considered statistically significant.  
 
3.  Results and Analysis 
Research results 
The data of the research subject characteristics that include gender, age, type of vitiligo, and 
leukotrichia is presented in Table 1. 
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Table 1 
Characteristics of research subjects 
 
No Characteristics 
Active vitiligo Stable vitiligo 
(n = 40) (n = 30) 
1 Gender 
    
 
Male 24 (60) 17 (56.7) 
 
Female  16 (40)  13 (43.3)  
2 Age (years) 44 (860) 
 
45 (1566) 
 3 Vitiligo pattern   
 Segmental  7 (17.5)  2 (6.6)  
 Non-segmental 33 (82.5)  28 (93.3)  
4           Leukotrichia 6 (15)  2 (6.7)  
5 VASI score 4.1  3.3  1.5  0.9 
 6 IFN-  level 7.16  11.52  0.85  0.38 
7 TNF- level 2.07  1.03  1.06  0.20  
       *The value is presented in median form (range), n = number (%), mean  standard deviation 
 
The total samples were 70 cases of vitiligo, the median age of active vitiligo was 44 (860) and stable 
vitiligo was 45 (1566). The most subjects were 41 (58.5%) males compared to 29 (41.5%) females. 
The most common type of vitiligo was non-segmental 6 1 (87.1%) followed by segmental 9 (12.9%).  
Leukotrichia was more prevalent in active vitiligo than stable vitiligo. The mean of VASI score was 
higher in active vitiligo (4.1  3.3) compared to stable vitiligo (1.5  0.9). Mean serum levels of IFN- in 
active vitiligo was higher (7.16  11.52) than stable vitiligo (0.85  0.38). Mean serum levels of TNF- 
was higher (2.07  1.03) than stable vitiligo (1.06  0.20). 
 
Table 2 
Multivariate correlation between TNF- and IFN- levels with vitiligo progressivity towards age and 
gender 
 
Parameter Adjusted PR Confidence interval p-value 
TNF- 390.89 27.98-5460.12 0,001 
IFN- 341.06 33.04-3482.26 0.001 
95% confidence interval, PR: Prevalence Ratio, p-value <0.05 significant. 
 
The adjusted PR value towards serum levels of TNF- was 390.89 (CI 95% 27.98-5460.12; p <0,001). It 
defined that high serum levels of TNF- significantly increase the risk of vitiligo progression. The adjusted 
PR value towards serum levels of IFN- was 341.06 (CI 95% 33.40-3482.26; p <0,001). It defined that 
high serum levels of IFN- significantly increase the risk of vitiligo progression. 
 
Analysis  
The clinical course of vitiligo, particularly generalized vitiligo is not easy to be predicted. However, it is 
generally slowly progressive and hard to be controlled with therapy [10]. Clinical, histological, and 
biological approach to assess vitiligo progression has been done and each has limitations. In 
previous studies about vitiligo progression assessment by measuring the pro-inflammatory cytokines 
levels in vitiligo patient serum, it was reported that there were changes in cytokine expression. [1], [2]. 
The result showed that high serum levels of TNF- and IFN- as a  risk factor for vitiligo progression. 
Leukotrichia is usually found on the surface of the depigmented skin or in vitiligo patches due to loss 
of m e l a n o c y t e s  in t h e  h a i r  bulb a f t e r  t h e  destruction o f  t h e  epidermal melanocytes.  Due t o  
the immunologic process attested to the discovery of lymphocyte infiltration in dermis or perifollicular. 
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This phenomenon is found during the active vitiligo phase [11].  In this study, leukotrichia was found to 
be in higher proportion in active vitiligo. 
Inactive vitiligo, there is a change in the number and function of T cells, that is increased number of  CD 8 
+ T-cell and decreased of T reg cells that correlate with the vitiligo severity [11]. In vitiligo lesions, it is 
found that Th1 is the predominant cells that release various cytokines, one of them is TNF-. It is proven 
by a research conducted by Laddha et al, were reported serum levels of TNF- increased in vitiligo 
patients compared with healthy control [3]. 
Tumor necrosis factor- plays a role in the immunopathogenesis of vitiligo.  T h i s  c y t o k i n e  
induces mortality and melanocyte cell dysfunction through various mechanisms.  An infiltration  
and induction of Th1  cell response will increase TNF- level resulting in increased expression of 
nuclear factor kappa-B (NF-B). It plays a major role in regulating cell survival and repair genes. An 
increased NF-B expression will cause apoptosis of melanocyte cells. The high TNF- level is also 
caused expression of adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1) in 
melanocytes that will be marked by T cells as a target to be destroyed through immunologic cytotoxic 
processes [12]. 
TNF- cytokine inhibits melanogenesis through decreasing level and activity of tyrosinase enzyme 
and tyrosinase-related protein-1, decreasing MITF expression which is a transcription factor that plays 
a role in proliferation, survival, the death of melanocyte and regulates the melanogenesis process. TNF-  
also inhibits the melanocytes proliferation by increasing CXC-chemokine receptor II expression. It has 
also been shown that high levels of TNF- decreases pigment-associated antigen HMB-45 and K.1.2 
expression in melanocyte culture. Another mechanism that causes melanogenesis changes in vitiligo is 
TNF- decreases - Melanocyte- Stimulating Hormone (-MSH) activity and Melanocortin-1 Receptor 
(MCI-R) expression that plays a role in the pigmentation and melanocyte survival [12].  Redox 
hemostasis changes in vitiligo pathogenesis were reported by Glassman. High TNF-level induces an 
excessive production of ROS (NO, H2O2) which leads to an increase in melanocyte apoptosis in vitiligo [12], 
[13], [20]. 
IFN- is a pleiotropic cytokine that plays a role to regulate the immune system produced by T helper 
cells, natural cell killer, and keratinocytes. It plays an important role to induce depigmentation in vitiligo. 
The cytokines cause the formation of anti-melanocyte antibodies or activate cytotoxic T cells. Yang et al 
reported many CD8+ cytotoxic T lymphocyte cell infiltration and elevation of IFN- levels in progressive 
vitiligo [14]. The activation of CD8+ cytotoxic T lymphocyte is a source of IFN- levels elevations. 
An invitro research (primary culture human melanocyte) showed IFN- inhibited melanogenesis by 
changing the expression of mRNA of the melanogenic enzyme and the more important was IFN- 
induced direct apoptosis of melanocytes [14]. Son et al reported that IFN- is also inhibited -MSH 
hormone by decreasing MITF expression [15], [21]. 
IFN- signal bounds with IFN-  receptor via JAK I and JAK 2, leading to phosphorylation initiation of 
transducer signal, STAT 1+  transcription activation and translocation to the further nucleus induced IFN-
gene transcription, including gene chemokine ligan 9  (  CXCL9) and chemokine ligand  10  
(CXCL10). Those chemokines (CXCL9 and CXCL10) recruits an autoreactive CD 8 + T cells to the skin 
cause melanocyte apoptosis. CXCL 10 is directly contributes to T cells migration [15], [16], [17]. CXCL10 
receptor in CD 8+ autoreactive T cells, CXCR3 is highly expressed on the skin of vitiligo lesions. Based on 
those study findings, current vitiligo therapy research focuses on  IFN--CXCL10-CXCR3 axis pathway,  a  
potential therapeutic target in vitiligo [16], [18]. 
Interferon-gamma indirectly increases ICAM-1 expression in melanocytes and increases melanocyte 
attachment with T cells in the skin, resulting in melanocyte defective. ICAM-1 expression also induces  B 
cells activity that increases the autoantibodies production leading to melanocyte cell 
defective[19],[22]. 
 
4.  Conclusion 
Cytokines play a role in regulating the immune response and depigmentation process in vitiligo. 
There is an imbalance of cytokine levels in patients with vitiligo. The cytokines of TNF- and IFN- 
expression play a role in the autoimmune process of vitiligo. The expression of cytokines TNF- and IFN- 
are associated with melanocyte destruction in the active phase of vitiligo lesions. This study proved high 
serum levels of TNF- and IFN- were the risk factors for vitiligo progression. Further studies about 
TNF- levels and IFN- levels before and after treatment in vitiligo patients with large samples are 
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needed to confirm this study results. More studies about the role of TNF- and IFN- inhibitor for vitiligo 
patient are needed as the treatment option in vitiligo.  
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